))
113 – Tasigna approved for children with CML; FDA approves ranibizumab injection) 0.3 mg Prefilled Syringe; FDA Clearance for HandX; ExSpiron for Pediatric Patients
Archived series ("Inactive feed" status)
When?
This feed was archived on October 07, 2018 00:40 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 201503119 series 1587676
Content provided by Emma Nichols. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Emma Nichols or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
March 23, 2018
Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com
1:23 Novartis drug Tasigna® approved by FDA to treat children with chronic myeloid leukemia https://www.prnewswire.com/news-releases/novartis-drug-tasigna-approved-by-fda-to-treat-children-with-rare-form-of-leukemia-300618326.html
3:02 FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy | Business Wire https://www.businesswire.com/news/home/20180321005688/en/FDA-Approves-Genentech%E2%80%99s-Lucentis-ranibizumab-injection-0.3
5:11 FDA Clearance for HandX, the First in a Line of Smart Digital Handtop Solutions https://www.prnewswire.com/news-releases/human-xtensions-receives-fda-clearance-for-its-handx-the-first-in-a-line-of-smart-digital-handtop-solutions-677636573.html
6:26 FDA clearance for use of the ExSpiron™ 1Xi Minute Ventilation Monitor in Pediatric Patients https://www.prnewswire.com/news-releases/respiratory-motion-inc-is-excited-to-announce-fda-clearance-for-use-of-the-exspiron-1xi-minute-ventilation-monitor-in-pediatric-patients-300617953.html
The next 6-week course will begin on Monday April 9th, 2018. Registration for the course will begin on Monday April 2nd, at noon EDT and will close on Saturday April 7th at noon EDT. Log on to learn.6weekcourse.com to register. Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
100 episodes
Share
